Bionano Genomics Inc (BNGO)
0.9294
+0.05
(+5.24%)
USD |
NASDAQ |
May 01, 14:20
Bionano Genomics Cash from Investing (TTM): 24.16M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 24.16M |
September 30, 2023 | 91.14M |
June 30, 2023 | 65.67M |
March 31, 2023 | 67.33M |
December 31, 2022 | 82.77M |
September 30, 2022 | -21.35M |
June 30, 2022 | -214.91M |
March 31, 2022 | -246.07M |
December 31, 2021 | -278.06M |
September 30, 2021 | -185.55M |
June 30, 2021 | -2.40M |
March 31, 2021 | -2.474M |
December 31, 2020 | -2.45M |
Date | Value |
---|---|
September 30, 2020 | -2.473M |
June 30, 2020 | -0.0311M |
March 31, 2020 | -0.0611M |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | -0.3317M |
September 30, 2018 | -0.6017M |
June 30, 2018 | -0.7453M |
March 31, 2018 | -0.9581M |
December 31, 2017 | -1.018M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-278.06M
Minimum
Dec 2021
91.14M
Maximum
Sep 2023
-39.05M
Average
-2.425M
Median
Cash from Investing (TTM) Benchmarks
Bruker Corp | -326.00M |
Azenta Inc | 473.42M |
Harvard Bioscience Inc | -1.799M |
Akoya Biosciences Inc | 3.347M |
Singular Genomics Systems Inc | 13.81M |